CRA International (UK) Limited
Charles River Associates (CRA) is a global consulting firm specializing in strategy and management consulting, guiding businesses through critical strategy and operational issues.
For more than 25 years, life science companies, law firms, and regulatory agencies around the globe have turned to CRA’s life sciences consultants when they need clarity and solutions to the industry’s most complex issues. Clients value our deep industry knowledge, rigorous analytic techniques, and decades of hands-on experience spanning thousands of successful engagements.
Since 1965, clients have engaged CRA for our unique combination of functional expertise and industry knowledge, and for our objective solutions to complex problems. Headquartered in Boston, CRA has offices throughout the world.
Click here to learn more.
Products and services
Corporate, Portfolio, & Brand Strategy
For 25 years, our global team of senior experts has helped Life Science firms anticipate trends and break through strategic barriers. CRA’s fit-for-purpose designs go beyond a single project, to build a true strategic partnership, providing cross-functional support across industry stakeholders and geographies. Clients rely on CRA’s institutional knowledge and subject matter expertise to provide an independent perspective to address core business issues, drive change, and align internal stakeholders.
Our Focus Areas:
- Market understanding
- Opportunity assessment
- Commercial strategy
- Clinical and medical strategy
- Portfolio strategy
- Medical affairs
Pricing & Market Access
Price and access decisions are critical for maximizing the lifecycle value of an asset or franchise. Life sciences companies seeking to develop successful pricing and access strategies must navigate the complex and evolving interactions between customers and products, and must ensure that their decisions balance strategic and financial goals while enabling appropriate access and reimbursement to medical providers, patients, and caregivers.
Our Focus Areas:
- Price, access, and reimbursement environment scanning
- Payer/HTA value driver assessment and evidence planning
- List and net price strategies across asset lifecycle
- Innovative contract design and implementation
- Portfolio-level price and access optimization
- Pricing for rare/orphan disease, oncology, and curative therapies
- Patient access and affordability solutions
- Commercial assessments to support investment decisions
Life Sciences Policy
CRA’s policy team provides analysis and insights into global, regional and national policy issues affecting patients, the healthcare system, and the life sciences industry. CRA has a reputation for independence and rigor, benefiting from long standing relationships with most leading life sciences organizations as well as national governments and the European Commission and industry associations. Our specialist team has provided unique policy oversight for the past 20 years delivering high quality, robust analysis but in a compelling fashion that is accessible to the target audience, whomever it may be.
Our Focus Areas:
-
EU, US Federal and State related policy issues
-
Market related policy issues affecting global markets
-
Healthcare financing and international health policies
-
Diagnostics and medical devices
Life Sciences Litigation
CRA’s life sciences litigation support services are grounded in a comprehensive understanding of pharmaceutical, biotechnology, medical device, and diagnostic markets. For more than 30 years, our experts have consulted with major life science companies, law firms, and regulatory agencies around the globe. We provide clients with the industry and analytical expertise needed to solve our clients’ most complex issues.
CRA has a reputation for delivering rigorous analysis and expert testimony. Economic expertise is complemented by experience assisting life sciences companies with business and policy issues. This combination allows CRA to provide effective expert testimony and support.
Our Focus Areas:
- Intellectual Property
- Commercial Disputes
- Antitrust & Competition
- Government & Regulatory Investigations
- Transfer Pricing & Tax Disputes
- Securities Litigation
